Fingerprint
Dive into the research topics of 'Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer
J Feliu, P Borrega, A León, L López-Gómez, M López, J Castro, C Belda-Iniesta, J Barriuso, V Martínez, M González-Barón
Research output: Contribution to journal › Article › peer-review